Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.

Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
See the people, processes, and equipment fueling Professor Lingjun Li’s internationally recognized research program.
From COVID-19 to encephalitic alphaviruses, School of Pharmacy Associate Professor Jennifer Golden and collaborators are developing new antiviral treatments.
Associate Professor Jason Kwan launches a new course to help undergraduates explore soil microbes and build hands-on skills in bioinformatics.
Funded by multiple grants, alum Russ Lehrman (PhD ‘81) is developing a new therapeutic to revolutionize pulmonary care, starting with preterm infants.
Supported by a prestigious national fellowship and UW traineeship, Pharmaceutical Sciences graduate student Christopher Stevens is expanding the application of a future therapeutic.
During the annual American Association of Pharmaceutical Scientists’ PharmSci 360 conference, the University of Wisconsin–Madison School of Pharmacy hosted a reception to gather Badger researchers from around the nation to catch up and build new connections.
Postdoctoral scientist Sarah Neuman and Professor Arash Bashirullah find bridge-shaped proteins that channel the flow of essential lipids inside cells.
Alum Elham Nejati (PhD ’12) advances new therapeutics through formulation and process development at Gilead Sciences.
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move therapies from the lab into the clinic.